#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16226	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2098	768.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	928	C,A	836,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30642	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3530	865.6	0	.	n	.	0	T695C	SNP	695	695	T	990	990	C	923	C,A	833,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30642	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3530	865.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1933	1933	G	1035	G,A	916,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30642	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3530	865.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2266	2266	C	1016	C	898	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30642	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3530	865.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2340	2340	A	952	A	860	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30642	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3530	865.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2892	2892	C	953	C,A	858,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2392	folP	855	855	100.0	folP.l15.c4.ctg.1	1347	175.6	1	SNP	p	R229S	1	.	.	685	687	AGC	887	889	AGC	230;227;229	A;G;C,A	206;206;206,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	168.1	1	SNP	p	S91F	1	.	.	271	273	TTC	570	572	TTC	147;145;144	T;T;C	135;133;134	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	168.1	1	SNP	p	D95G	1	.	.	283	285	GGC	582	584	GGC	155;156;155	G;G;C	144;145;144	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5618	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	168.1	1	SNP	p	G95N	0	.	.	283	285	GGC	582	584	GGC	155;156;155	G;G;C	144;145;144	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1774	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1222	143.5	1	SNP	p	G45D	0	.	.	133	135	GGC	338	340	GGC	240;237;239	G;G;C	212;204;208	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	854	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	955	88.7	0	.	n	.	0	A197.	DEL	197	197	A	505	505	A	221	A	194	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5952	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2921	203.3	1	SNP	p	D86N	0	.	.	256	258	GAC	564	566	GAC	234;234;234	G;A;C	206;201;206	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5952	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2921	203.3	1	SNP	p	S87R	1	.	.	259	261	CGT	567	569	CGT	232;228;227	C;G;T	207;202;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5952	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2921	203.3	1	SNP	p	R87I	0	.	.	259	261	CGT	567	569	CGT	232;228;227	C;G;T	207;202;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5952	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2921	203.3	1	SNP	p	R87W	0	.	.	259	261	CGT	567	569	CGT	232;228;227	C;G;T	207;202;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5952	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2921	203.3	1	SNP	p	S88P	0	.	.	262	264	TCC	570	572	TCC	230;229;230	T;C;C	205;204;205	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4874	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2573	188.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1544	1546	GGC	216;214;209	G;G;C,T	196;195;185,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1277	1279	GCC	230;232;235	G,A;C;C,T	202,1;204;205,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1280	1282	ATG	238;241;244	A;T;G	208;212;213	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1292	1294	ACC	251;249;251	A;C;C,T	219;221;222,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1292	1294	ACC	251;249;251	A;C;C,T	219;221;222,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1793	1795	ACC	254;257;257	A;C;C	227;233;233	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1847	1849	GCG	237;236;243	G;C;G	208;208;211	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1847	1849	GCG	237;236;243	G;C;G	208;208;211	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1970	1972	GGT	204;202;200	G;G;T	182;179;173	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1979	1981	AGC	197;194;192	A;G;C	167;165;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2526	183.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1997	1999	CCG	174;177;174	C,G;C,G;G	127,3;126,1;130	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6318	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2899	216.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1515	1517	CCG	249;247;251	C;C;G	212;213;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2478	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1622	151.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	487	487	C	185	C	165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3088	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	201.5	1	SNP	p	G120K	1	.	.	358	360	AAG	590	592	AAG	273;272;275	A;A;G	244;247;245	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3088	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	201.5	1	SNP	p	N121D	0	.	.	361	363	AAC	593	595	AAC	275;272;273	A;A;C	245;243;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3088	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	201.5	1	SNP	p	A121N	1	.	.	361	363	AAC	593	595	AAC	275;272;273	A;A;C	245;243;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11926	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4791	248.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1232	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	967	125.6	1	SNP	p	V57M	1	.	.	169	171	ATG	449	451	ATG	252;251;252	A;T,A;G	229;227,1;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
